107 related articles for article (PubMed ID: 38753747)
1. Nuclear Medicine Cancer Care-Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer.
O'Brien SR; Mankoff DA
Cancer J; 2024 May-Jun 01; 30(3):140-141. PubMed ID: 38753747
[No Abstract] [Full Text] [Related]
2. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
3. Theranostic Outcomes in Clinical Practice of Oncology: What, So What, Now What? What's More.
Turner JH
Cancer Biother Radiopharm; 2019 Apr; 34(3):135-140. PubMed ID: 30973278
[No Abstract] [Full Text] [Related]
4. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
5. Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs.
Miller C; Rousseau J; Ramogida CF; Celler A; Rahmim A; Uribe CF
Theranostics; 2022; 12(1):232-259. PubMed ID: 34987643
[TBL] [Abstract][Full Text] [Related]
6. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
7. Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
Czernin J
J Nucl Med; 2019 Aug; 60(8):1037. PubMed ID: 31371618
[No Abstract] [Full Text] [Related]
8. [Nuclear medicine diagnostics, therapy and theranostics in the context of modern oncology].
Schaefer N; Prior J
Ther Umsch; 2019 Sep; 76(4):167-172. PubMed ID: 31498036
[TBL] [Abstract][Full Text] [Related]
9. Theranostic and nanotheranostic probes in nuclear medicine.
Drude N; Tienken L; Mottaghy FM
Methods; 2017 Nov; 130():14-22. PubMed ID: 28698069
[TBL] [Abstract][Full Text] [Related]
10. Current and future aspects of nuclear molecular therapies: a model of theranostics.
Juweid ME; Mottaghy FM
Methods; 2011 Nov; 55(3):193-5. PubMed ID: 22153218
[No Abstract] [Full Text] [Related]
11. Nuclear Medicine in Cancer Theranostics: Beyond the Target.
Taïeb D; Hicks RJ; Pacak K
J Nucl Med; 2016 Nov; 57(11):1659-1660. PubMed ID: 27445288
[No Abstract] [Full Text] [Related]
12. Radiopharmaceutical enhancement by drug delivery systems: A review.
Kleynhans J; Grobler AF; Ebenhan T; Sathekge MM; Zeevaart JR
J Control Release; 2018 Oct; 287():177-193. PubMed ID: 30086338
[TBL] [Abstract][Full Text] [Related]
13. Alpha emitting nuclides in nuclear medicine theranostics.
Miederer M
Nuklearmedizin; 2022 Jun; 61(3):273-279. PubMed ID: 34624903
[TBL] [Abstract][Full Text] [Related]
14. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
15. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
16. Highlights from 2017: impactful topics published in the Annals of Nuclear Medicine.
Farolfi A; Ghedini P; Fanti S
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):217-223. PubMed ID: 30267115
[TBL] [Abstract][Full Text] [Related]
17. Production and regulatory issues for theranostics.
Giammarile F; Paez D; Zimmermann R; Cutler CS; Jalilian A; Korde A; Knoll P; Ayati N; Lewis JS; Lapi SE; Delgado Bolton RC; Kunikowska J; Estrada Lobato E; Urbain JL; Holmberg O; Abdel-Wahab M; Scott AM
Lancet Oncol; 2024 Jun; 25(6):e260-e269. PubMed ID: 38821100
[TBL] [Abstract][Full Text] [Related]
18. Molecular theranostics: a primer for the imaging professional.
Lee DY; Li KC
AJR Am J Roentgenol; 2011 Aug; 197(2):318-24. PubMed ID: 21785076
[TBL] [Abstract][Full Text] [Related]
19. Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics.
Scott AM; Zeglis BM; Lapi SE; Scott PJH; Windhorst AD; Abdel-Wahab M; Giammarile F; Piaez D; Jalilian A; Knoll P; Korde A; Vichare S; Ayati N; Lee ST; Lyashchenko SK; Zhang J; Urbain JL; Lewis JS
Lancet Oncol; 2024 Jun; 25(6):e250-e259. PubMed ID: 38821099
[TBL] [Abstract][Full Text] [Related]
20. [Oncological theranostics in nuclear medicine].
Laschinsky C; Herrmann K; Fendler W; Nader M; Lahner H; Hadaschik B; Sandach P
Radiologie (Heidelb); 2022 Oct; 62(10):875-884. PubMed ID: 36112174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
